Literature DB >> 1401747

Preclinical hypogonadism in genetic hemochromatosis in the early stage of the disease: evidence of hypothalamic dysfunction.

A Piperno1, M R Rivolta, R D'Alba, S Fargion, F Rovelli, A Ghezzi, M Micheli, G Fiorelli.   

Abstract

We studied endocrine functions at baseline and after TRH and LHRH stimulation in a group of 7 young male patients with genetic hemochromatosis (HE) without liver damage (i.e. fibrosis and cirrhosis). In five patients endocrine re-evaluations after complete iron depletion was also performed. Mean basal testosterone (T), FSH, LH and PRL were significantly lower than in controls. Serum T increased normally after HCG stimulation. The normal or high increments of LH after LHRH stimulation suggest that secretion capacity of LH was intact and that hypothalamic dysfunction could be responsible for the preclinical gonadal deficiency found in our patients. The response of PRL to TRH indicates that secretion capacity of lactotrophs although present, was decreased and did not improve after phlebotomy therapy. After iron depletion the two patients with the lowest basal T levels showed the highest increments indicating that in the early stages of hypothalamic-pituitary damage gonadal dysfunction is still reversible in HE patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401747     DOI: 10.1007/BF03348765

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

1.  Decreased prolactin reserve in hemochromatosis.

Authors:  C L Levy; H E Carlson
Journal:  J Clin Endocrinol Metab       Date:  1978-08       Impact factor: 5.958

2.  Hemochromatosis and hemosiderosis. Study of 211 autopsied cases.

Authors:  R A MACDONALD; G K MALLORY
Journal:  Arch Intern Med       Date:  1960-05

3.  [Pituitary investigations in idiopathic haemochromatosis (author's transl)].

Authors:  J P Bercovici; T Darragon; J Caroff; J Le Roy
Journal:  Sem Hop       Date:  1979 Oct 18-25

4.  Pituitary function in idiopathic haemochromatosis: hormonal study in 36 male patients.

Authors:  B Charbonnel; M Chupin; A Le Grand; J Guillon
Journal:  Acta Endocrinol (Copenh)       Date:  1981-10

5.  Androgen and estrogen response to adrenal and gonadal stimulation in idiopathic hemochromatosis: evidence for decreased estrogen formation.

Authors:  H K Kley; W Stremmel; C Niederau; R Hehrmann; O Shams; G Strohmeyer; H L Krüskemper
Journal:  Hepatology       Date:  1985 Mar-Apr       Impact factor: 17.425

6.  Hypogonadism in hemochromatosis: reversal with iron depletion.

Authors:  T M Kelly; C Q Edwards; A W Meikle; J P Kushner
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

7.  Thyroid disease in hemochromatosis. Increased incidence in homozygous men.

Authors:  C Q Edwards; T M Kelly; G Ellwein; J P Kushner
Journal:  Arch Intern Med       Date:  1983-10

8.  Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study.

Authors:  C Bergeron; K Kovacs
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

9.  Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.

Authors:  C Wang; S C Tso; D Todd
Journal:  J Clin Endocrinol Metab       Date:  1989-03       Impact factor: 5.958

10.  The endocrine manifestations of hemochromatosis.

Authors:  L W McNeil; L C McKee; D Lorber; D Rabin
Journal:  Am J Med Sci       Date:  1983 May-Jun       Impact factor: 2.378

View more
  4 in total

1.  Haemochromatosis as an endocrine cause of subfertility.

Authors:  M J Tweed; J M Roland
Journal:  BMJ       Date:  1998-03-21

2.  Basal endocrine status in African dietary iron overload.

Authors:  Lynette McNamara; Vanessa R Panz; Frederick J Raal; Janice Paiker; Barry I Joffe; Victor R Gordeuk; A Patrick MacPhail
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

Review 3.  Endocrine dysfunction in hereditary hemochromatosis.

Authors:  C Pelusi; D I Gasparini; N Bianchi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2016-03-07       Impact factor: 4.256

Review 4.  Beta-thalassemia major and female fertility: the role of iron and iron-induced oxidative stress.

Authors:  Paraskevi Roussou; Nikolaos J Tsagarakis; Dimitrios Kountouras; Sarantis Livadas; Evanthia Diamanti-Kandarakis
Journal:  Anemia       Date:  2013-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.